关注
Yesim Gokmen-Polar
Yesim Gokmen-Polar
Associate Professor
在 emory.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
The integrated genomic landscape of thymic epithelial tumors
M Radovich, CR Pickering, I Felau, G Ha, H Zhang, H Jo, KA Hoadley, ...
Cancer cell 33 (2), 244-258. e10, 2018
3222018
Elevated protein kinase C βII is an early promotive event in colon carcinogenesis
Y Gökmen-Polar, NR Murray, MA Velasco, Z Gatalica, AP Fields
Cancer research 61 (4), 1375-1381, 2001
2442001
Protein kinase Cι is required for Ras transformation and colon carcinogenesis in vivo
NR Murray, L Jamieson, W Yu, J Zhang, Y Gökmen-Polar, D Sier, ...
The Journal of cell biology 164 (6), 797, 2004
1872004
HSF1 as a cancer biomarker and therapeutic target
RL Carpenter, Y Gökmen-Polar
Current cancer drug targets 19 (7), 515-524, 2019
1032019
EphA2 overexpression decreases estrogen dependence and tamoxifen sensitivity
M Lu, KD Miller, Y Gokmen-Polar, MH Jeng, MS Kinch
Cancer research 63 (12), 3425-3429, 2003
982003
Ductal carcinoma in situ of breast: update 2019
SS Badve, Y Gökmen-Polar
Pathology 51 (6), 563-569, 2019
872019
DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer
S Woditschka, L Evans, R Duchnowska, LT Reed, D Palmieri, Y Qian, ...
JNCI: Journal of the National Cancer Institute 106 (7), dju145, 2014
852014
Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models
Y Gökmen-Polar, Y Liu, RA Toroni, KL Sanders, R Mehta, S Badve, ...
Breast cancer research and treatment 136, 673-682, 2012
822012
Extrathoracic metastases of thymic origin: a review of 35 cases
T Vladislav, RK Jain, R Alvarez, RJ Mehta, Y Gökmen-Polar, KA Kesler, ...
Modern Pathology 25 (3), 370-377, 2012
822012
CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer
KE Craven, Y Gökmen-Polar, SS Badve
Scientific Reports 11 (1), 4691, 2021
762021
Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model
R Shanmugam, V Jayaprakasan, Y Gokmen‐Polar, S Kelich, KD Miller, ...
The Prostate 66 (14), 1498-1511, 2006
702006
Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers
Y Gökmen-Polar, IT Vladislav, Y Neelamraju, SC Janga, S Badve
Scientific reports 5 (1), 8765, 2015
692015
Splicing factor ESRP1 controls ER‐positive breast cancer by altering metabolic pathways
Y Gökmen‐Polar, Y Neelamraju, CP Goswami, Y Gu, X Gu, G Nallamothu, ...
EMBO reports 20 (2), e46078, 2019
672019
Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients
R Duchnowska, J Jassem, CP Goswami, M Dundar, Y Gökmen-Polar, L Li, ...
Journal of Neuro-oncology 122, 205-216, 2015
652015
Protein kinase C-β as a therapeutic target in breast cancer
GW Sledge Jr, Y Gökmen-Polar
Seminars in oncology 33, 15-18, 2006
632006
Mapping of a molecular determinant for protein kinase C βII isozyme function
Y Gökmen-Polar, AP Fields
Journal of Biological Chemistry 273 (32), 20261-20266, 1998
611998
Expression levels of SF3B3 correlate with prognosis and endocrine resistance in estrogen receptor-positive breast cancer
Y Gökmen-Polar, Y Neelamraju, CP Goswami, X Gu, G Nallamothu, ...
Modern pathology 28 (5), 677-685, 2015
562015
Single-cell heterogeneity in ductal carcinoma in situ of breast
MJ Gerdes, Y Gökmen-Polar, Y Sui, AS Pang, N LaPlante, AL Harris, ...
Modern Pathology 31 (3), 406-417, 2018
552018
Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer
Y Gökmen-Polar, RA Toroni, BA Hocevar, S Badve, Q Zhao, C Shen, ...
Breast cancer research and treatment 127, 375-384, 2011
542011
The role of histology in predicting recurrence of type A thymomas: a clinicopathologic correlation of 23 cases
IT Vladislav, Y Gökmen-Polar, KA Kesler, PJ Loehrer Sr, S Badve
Modern Pathology 26 (8), 1059-1064, 2013
532013
系统目前无法执行此操作,请稍后再试。
文章 1–20